On the Record · Sage Therapeutics

Sage Therapeutics acquisitions, on the record

The businesses Sage Therapeutics bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.

Deals its annual reports describe

Sage Therapeutics’s annual reports for 2022 to 2024 name no acquisition or sale of a business.

Deal filings since 2016

2025-07-31 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
2025-06-16 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2024-01-24 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2023-11-07 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2020-11-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2019-02-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2018-02-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2017-11-15 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-09-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-05-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
2016-01-07 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement

Read from Sage Therapeutics’s annual reports (10-K for 2024, 10-K for 2023, 10-K for 2022) and the financial data it files with the SEC, as of 2025-02-11. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.